This site uses cookies to improve your experience.
We’ll assume you’re okay with this, but you can opt out if you wish.

Back to In The News

Enfusion Announces Date of Fourth Quarter and Full Year 2023 Results

Feb.13.2024

February 13, 2024

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its fourth quarter and full year 2023 financial results before the U.S. financial markets open on Tuesday, March 12, 2024. Management will host a conference call and webcast that same morning at 5:30 AM (PT) / 8:30 AM (ET) to discuss the results.

To access this call, dial (888) 596-4144. The conference ID number is 9652536. A live webcast of this conference call will be available on the Investor Relations page of Enfusion’s website, https://ir.enfusion.com, and a replay will be archived on the website as well.

About Enfusion

Enfusion's investment management software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration boosting agility and powering growth. Enfusion partners with over 800 investment managers from 10 global offices spanning four continents.

Contacts

Investors

Source: Enfusion, Inc.

Source Code: ENFN-IR

ENFN-CORP

Share

Copy

Media Contact

For media inquiries, please contact:

Gain a clear advantage.

Talk to Us